Report

Fighting COVID-19: What our members are doing

Read about the activities of EuropaBio and its members in response to the COVID-19 pandemic

We are very proud of our members working hard to fight COVID-19. Their commitment demonstrates the distinctive potential of the biotechnology industry to fight COVID-19. Find the more information on how the biotech & life science industry comes together in the fight against COVID-19.

 

AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance - Read More

AbbVie Donates $35 Million for COVID-19 Relief to Support Healthcare Systems, Patients and Communities - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include: Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

The Alexion Charitable Foundation is donating a total of $500,000 across three nonprofit organizations - Read More

Alexion Announces Plans to Initiate Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19 - Read More

Amgen and Adaptive Biotechnologies announce strategic partnership to develop a therapeutic to prevent or treat COVID-19 - Read More

Amgen and The Amgen Foundation commit up to $12.5 Million to support COVID-19 relief efforts - Read More

NEJM publishes study results from Amgen subsidiary deCODE Genetics. The study looked at the early spread of SARS-Cov-2 virus in Iceland with the aim of gaining insight into how the virus spreads - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

  

ARD, solidarity of healthcare players in the greater east and Vivescia Group comapnies - Read More (FR)

AseBio reports on a platforms that helps to detect, track and guide the treatmentof COVID-19 with medical images - Read More (ESP)

Biotechnology leads the fight against the coronavirus - Read More (ESP)

BASF significantly expands sanitizer production in Ludwigshafen and supports VCI platform for nationwide emergency provision - Read More

BASF donates over 100 million protective masks - Read More

“Helping Hands” campaign: BASF provides hospitals in the German Rhine-Neckar metropolitan region with free hand sanitizer - Read More

In Ghent, BASF supplied lab equipment to help Belgium perform more than 10,000 tests a day - Read More (NL)

Bayer's Commitment During the Coronavirus Pandemic - Read More

Bayer's newly established testing laboratory in Berlin is already running: In the lab, our employees are able to conduct up to 1,000 additional SARS-CoV-2 tests per day - Read More

Bayer announced a donation of one million products to support the health of underserved communities - Read More.

Bayer is making more than 40 virus diagnostic devices from its research facilities available at various locations in Germany - Read More

Bayer is donating 8 million tablets of chloroquine to the German government to support the fight against COVID-19 - Read More

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments - Read More

Coronavirus: Combating The Protective Mask Shortage - Read more

BIA action and guidance on COVID-19 - Read More

BIA UK sums up how the biotech industry has risen to the challenge that is COVID-19 - Read More

BIA welcomes £1 billion support package for innovative companies - Read More

Biome Makers adapt their patented microbiome NGS workflow to detect SARS-CoV-2 - Read More

Clariant starts monthly production of 2 million liters of disinfectant in Gendorf to support vital institutions during COVID-19 outbreak - Read more

Clariant is donating approximately 80 tons of disinfectant per month to the Swiss Federal Authorities to help with COVID-19 - Read more

Corteva's Commitment: We Support Those Who Support All of Us - Read More

Embracing innovation for a stable and secure food supply - Read More

CSL Behring’s Global Role in Battling COVID-19 - Read More

CSL Behring and SAB Biotherapeutics Join Forces to Deliver New Potential COVID-19 Therapeutic - Read More

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy - Read More

Experts from the world’s leading plasma companies have come together to create the CoVIg-19 Plasma Alliance aimed at treating the new coronavirus - Read more

CoVIg-19 Plasma Alliance builds a strong momentum through expanded membership and clinical trial collaboration - Read more

Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation - Read more

DSM Co-CEOs statement on the COVID-19 outbreak - Read More

Delivering 260,000 bottles of hand sanitizer to Dutch hospitals - Read More

DSM joins the European Alliance for a green recovery from the COVID19 crisis - Read More

The Dutch consortium of AFPRO Filters, Royal Auping, and Royal DSM has begun large-scale production of medical FFP2 facemasks in the Netherlands to protect healthcare workers against the coronavirus - Read more

DSM to help accelerate Dutch Covid-19 testing by making 2.8 million nose swabs and is donating the 11 tons of material required to make them - Read more

Evonik, as part of its chemical portfolio, has developed an environmentally safe way of disinfecting surfaces where coronavirus is present - Read More

Evonik, EOS, 3D Systems, HP Inc., and voxeljet bundle their expertise in additive manufacturing to support hospitals with 3D-printed medical devices used in the fight against the COVID-19 pandemic - Read More

COVID-19, GNS561’s Assault begins in France - Read More

Gilead working in consultation with regulatory authorities to establish additional expanded access programs for remdesivir, our investigational medicine for COVID-19 - Read More

Gilead Announces $20 Million Philanthropic Fund to Support Nonprofit Organizations Impacted by the COVID-19 Crisis - Read More

Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 - Read more

Gilead’s Investigational Antiviral Remdesivir Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of COVID-19 - Read more

Gilead Sciences Statement on NEJM Publication of Remdesivir Data From NIAID Study - Read more

Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 - Read more

Gilead Sciences Statement on Remdesivir Clinical Data - Read more

Ipsen donates €2 million to the Institut Pasteur to support research on COVID-19 - Read More

Johnson & Johnson Announces It Has Identified a Lead Covid-19 Vaccine Candidate - Read More

Johnson & Johnson Announces a $50 Million Commitment to Support Frontline Health Workers Battling Covid-19 - Read More

Johnson & Johnson is helping support healthcare workers on the frontlines of the COVID19 outbreak by providing over $3.7M in personal protective equipment - Read More

NBC took a look at J&J’s COVID-19 efforts, including how it is ramping up to meet its commitment to supply 1 billion vaccines globally - Watch the video

J&J tracks the path to a COVID-19 vaccine in new online news series - Read More

Johnson & Johnson scientists are fast at work on a potential vaccine for Covid-19 that the company plans to provide on a not-for-profit basis - Read More

Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company’s Goal to Supply More Than One Billion Vaccine Doses Globally - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

Johnson & Johnson are co-founding members of the Pandemic Action Network (PAN), a global advocacy network aimed at helping to end COVID-19 and stop future pandemics - Read more

Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July - Read more

Kedrion’s efforts are concentrated on the use of “convalescent plasma” (donated by patients who have recovered from the disease, and rich in anti-virus antibodies) - Read More

Kedrion and Kamada announce collaboration for Anti COVID-19 IGG - Read More

Lilly, Merck and Pfizer empower team members to volunteer on COVID-19 frontlines - Read More

Lilly Begins Clinical Testing of Therapies for COVID-19 - Read More

Lilly taps AbCellera to get coronavirus drug into clinic in 4 months - Read More

The Central Indiana COVID-19 Community Economic Relief Fund has given grants totaling $7.3M to 46 nonprofits. The Lilly Foundation and more funders established this to support orgs serving affected people - Read More

The Lilly Italy Foundation has donated 1 million euros of insulin produced at their site in Sesto Fiorentino to Italian hospitals to aid in the fight against COVID-19 - Read more (IT)

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include: Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 - Read more

Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans - Read more

Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment - Read more

 

Limagrain donates several hundred FFP3 masks and several thousand surgical masks - Read More (FR)

Merck collaborates with the Bill & Melinda Gates foundation to fight COVID-19 - Read More

Merck statement on Rebif (interferon beta-1a) donation to INSERM - Read More

Merck is donating 290,000 units of its interferon beta-1a (Rebif®) to the World Health Organization for use in their global SOLIDARITY trial - Read More

Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing - Read More

Merck is donating a total of two million FFP2 masks in Germany, France and the United States, among others - Read more

Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19 - Read more

How MSD is responding to the COVID-19 pandemic - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

MSD teams work together to donate more than $460,000 worth of supplies to the Indian Health Service National Supply Service Center - Read more

MSD and Ridgeback Biotherapeutics LP have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19 - Read more

MSD and IAVI have announced a new collaboration to develop an investigational vaccine against SARS-CoV-2 to be used for the prevention of COVID-19 - Read more

MSD to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by Themis and Institut Pasteur - Read more

NatureWorks partners with Nonwovens Institute to support production of 10 million N95 masks for healthcare workers fighting COVID-19 - Read More

Novartis donates 30.000 protection masks - Read More (GER)    

Novartis, Bill & Melinda Gates Foundation and life sciences companies commit expertise and assets to the fight against COVID-19 - Read More

Novartis donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical trial - Read More

Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program - Read More

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include: Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

International Rescue Committee announces $1 million contribution from Novartis in support of COVID-19 response in East Africa - Read more

Read all about how Novozymes supports communities coping with COVID-19 and how it is helping with testing and sanitizing - Read more

Catch-up with novo nordisk’s actions and contributiosn to fight COVID-19 all around the world - Read More

Novo Nordisk Foundation allocates DKK 50 million DKK for emergency response to the coronavirus epidemic in Denmark - Read More (DK)   

Together we can fight COVID-19 - Read More

The Novo Nordisk Foundation has awarded up to DKK 250 million to Statens Serum Institut (SSI) in connection with the establishment of a national COVID-19 test centre - Read More

Together with other partners, Rigshospitalet in Copenhagen and Novo Nordisk are closely collaborating on both the virus test and a reliable antibody test - Watch the video

 

 

Pfizer and BioNTech announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates - Read More

Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development - Read More

Pfizer and BioNTech to co-develop potential COVID-19 vaccine - Read More

Racing to Develop a Potential COVID-19 Vaccine with Unprecedented Partnership - Read More

Pfizer’s lead coronavirus drug is showing promise, chief scientific officer says - Read More

Lilly, Merck and Pfizer empower team members to volunteer on COVID-19 frontlines - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include: Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

Pfizer and BioNTech dose first participants in the US as part of Global COVID-19 mRNA vaccine development program - Read more

Pfizer has joined the COVID-19 Healthcare Coalition to Share Data to Fight COVID-19 - Read more

Recordati contributes to support hospitals and patients in the face of the epidemiologic emergency due to COVID‐19 - Read More

Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution - Read More

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 - Read More

Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries - Read More

Sanofi Mobilizes to Develop a Vaccine against COVID-19 - Read More

The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara® (sarilumab) in patients hospitalized with severe COVID-19 - Read More

Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients - Read More

Sobi to initiate a clinical study to evaluate whether anakinra and emapalumab may relieve complications associated with severe COVID-19 disease - Read More

Catchup with Syngenta's Coronavirus news - Read More

Syngenta to supply hand sanitizer to fight COVID-19 - Read More

Rajeev Venkayya, President, Global Vaccine Business Unit on the latest on the Coronavirus and Takeda - Read More

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy - Read More

The NIH is to launch public-private partnership to speed COVID-19 vaccine and treatment options. Some of the participating organisations from industry include: Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company, Merck & Co., Novartis, Pfizer and Takeda - Read More

Experts from the world’s leading plasma companies have come together to create the CoVIg-19 Plasma Alliance aimed at treating the new coronavirus - Read more

CoVIg-19 Plasma Alliance builds a strong momentum through expanded membership and clinical trial collaboration - Read more

Takeda will donate a total of JPY 2.5 billion (USD 23 million*) across three UN-led organizations to strengthen health systems, improve access to care and supplies, and address food insecurity - Read more

Takeda Supports IAEA Project Tackling COVID-19 Pandemic With €4.35 Million Donation. Read more 
 

 

The Vertex Foundation Commits $5 Million to Support Global COVID-19 Pandemic Response - Read More

The Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak Response - Read More

The Catalan biotechnology company, ZeCardio Therapeutics, a spin-off of ZeClinics which specializes in the field of heart disease, has already managed to raise more than half a million to fight COVID-19 - Read More (ES)